[
  {
    "ts": null,
    "headline": "Wells Fargo announces further layoffs at Jordan Creek campus",
    "summary": "Cuts forecast by CEO Charlie Scharf continue at Wells Fargo, with another round at the company's Jordan Creek facility.",
    "url": "https://finnhub.io/api/news?id=70843822b7d16493ca694c1a9770f00bf777724c299ea6d24f2bc81adba1412d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769190629,
      "headline": "Wells Fargo announces further layoffs at Jordan Creek campus",
      "id": 138226970,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WFC",
      "source": "Yahoo",
      "summary": "Cuts forecast by CEO Charlie Scharf continue at Wells Fargo, with another round at the company's Jordan Creek facility.",
      "url": "https://finnhub.io/api/news?id=70843822b7d16493ca694c1a9770f00bf777724c299ea6d24f2bc81adba1412d"
    }
  },
  {
    "ts": null,
    "headline": "Wells Fargo & Co. stock outperforms competitors despite losses on the day",
    "summary": "Wells Fargo & Co. stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=4ea591309fc8ced4eb014d92fb0e91890618923cb5c52b092dd67f6c6d909223",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769185920,
      "headline": "Wells Fargo & Co. stock outperforms competitors despite losses on the day",
      "id": 138233556,
      "image": "",
      "related": "WFC",
      "source": "MarketWatch",
      "summary": "Wells Fargo & Co. stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=4ea591309fc8ced4eb014d92fb0e91890618923cb5c52b092dd67f6c6d909223"
    }
  },
  {
    "ts": null,
    "headline": "Wells Fargo Remains a Buy on BridgeBio Pharma (BBIO)",
    "summary": "BridgeBio Pharma, Inc. (NASDAQ:BBIO) is one of the Best Russell 2000 Stocks to Buy Right Now. On January 20, Tiago Fauth from Wells Fargo reiterated a Buy rating on the stock and raised the price target to $88 from $84. Earlier on January 12, TD Cowen also reiterated a Buy rating on the stock with […]",
    "url": "https://finnhub.io/api/news?id=d4a4c3a18e1e902d2ad60235154fa451e9c3d92cdb306ec67f21ac99090ab679",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769172012,
      "headline": "Wells Fargo Remains a Buy on BridgeBio Pharma (BBIO)",
      "id": 138224804,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WFC",
      "source": "Yahoo",
      "summary": "BridgeBio Pharma, Inc. (NASDAQ:BBIO) is one of the Best Russell 2000 Stocks to Buy Right Now. On January 20, Tiago Fauth from Wells Fargo reiterated a Buy rating on the stock and raised the price target to $88 from $84. Earlier on January 12, TD Cowen also reiterated a Buy rating on the stock with […]",
      "url": "https://finnhub.io/api/news?id=d4a4c3a18e1e902d2ad60235154fa451e9c3d92cdb306ec67f21ac99090ab679"
    }
  },
  {
    "ts": null,
    "headline": "How Wells Fargo’s Bullish Coverage and Specialty Focus At Kinsale Capital Group (KNSL) Has Changed Its Investment Story",
    "summary": "In recent days, Wells Fargo initiated research coverage on Kinsale Capital Group, highlighting the insurer’s growth outlook supported by new product launches and an expanding specialty market, while other analysts struck a more cautious tone. Alongside this mixed analyst sentiment, Kinsale’s expanding premiums, rapid book value growth, and increased institutional ownership underscore how its niche in hard-to-place risks is shaping its long-term positioning. We’ll now examine how Wells...",
    "url": "https://finnhub.io/api/news?id=7a398dc2d935a1261207162ddea1ee39208554409c38dc5b9447f79e6f7b8caa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769130524,
      "headline": "How Wells Fargo’s Bullish Coverage and Specialty Focus At Kinsale Capital Group (KNSL) Has Changed Its Investment Story",
      "id": 138220279,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WFC",
      "source": "Yahoo",
      "summary": "In recent days, Wells Fargo initiated research coverage on Kinsale Capital Group, highlighting the insurer’s growth outlook supported by new product launches and an expanding specialty market, while other analysts struck a more cautious tone. Alongside this mixed analyst sentiment, Kinsale’s expanding premiums, rapid book value growth, and increased institutional ownership underscore how its niche in hard-to-place risks is shaping its long-term positioning. We’ll now examine how Wells...",
      "url": "https://finnhub.io/api/news?id=7a398dc2d935a1261207162ddea1ee39208554409c38dc5b9447f79e6f7b8caa"
    }
  }
]